clinical pathways

Department

Critical Considerations in Colorectal Pathway Development

09/19/2016

JCP Editors

In an early session at the Clinical Pathways Congress, Bert H O’Neil, MD, Indian University Simon Cancer Center (Indianapolis, IN) discussed some of the important factors to consider when developing a clinical...

In an...

09/19/2016

Journal of Clinical Pathways

Department

Keynote Presentation - Precision Medicine: An Essential Component of Oncology Clinical Pathways

09/17/2016

JCP Editors

Richard Schilsky, MD, senior vice president and chief medical officer of the American Society of Clinical Oncology kicked off the inaugural Clinical Pathways Congress with a discussion on the relationship between...

...

09/17/2016

Journal of Clinical Pathways

Research in Review

Mayo Clinic Outlines Pathways for Thrombotic Microangiopathies

09/06/2016

JCP Editors

Members of the Mayo Clinic in Rochester, MN, have provided guidelines for the creation of evidence-based clinical pathways for thrombotic microangiopathies (TMAs). TMAs are a diverse set of disorders sharing a...

...

09/06/2016

Journal of Clinical Pathways

Conference Preview

Shaping the Pathways of the Future

08/02/2016

JCP Editors

The Inaugural Clinical Pathways Congress September 16-18, 2016; Boston, MA As US expenditures on cancer-related treatments continue to grow, new solutions for managing these costs have increasingly become...

The...

08/02/2016

Journal of Clinical Pathways

Role of Pathways in Payment Reform

08/02/2016

JCP Editors

The final speaker, Blase N Polite, MD, MPP, The University of Chicago, introduced himself by saying, “My job is to convince you that pathways can fix things you don’t even know are a problem yet.” For more ASCO...

The...

08/02/2016

Journal of Clinical Pathways

Outcomes of a Clinical Pathways Program

08/02/2016

JCP Editors

J Russel Hoverman, MD, PhD, Texas Oncology, next spoke about the performance of clinical pathways in practice. Texas Oncology has used clinical pathways for the last 10 years. In collaboration with Aetna and with US...

J...

08/02/2016

Journal of Clinical Pathways

The Payer Perspective

08/02/2016

JCP Editors

Balancing out the provider perspective was Andrew Allan  Hertler, MD, FACP, New Century Health, who explained why clinical pathways are increasingly being used by payers as a tool for controlling oncology...

...

08/02/2016

Journal of Clinical Pathways

The Oncology Practice Perspective

08/02/2016

JCP Editors

In order to address the oncologist’s perspective on clinical pathways, James N Frame, MD, FACP, Charleston Area Medical Center, talked about some of the concerns that oncology care providers have about using clinical...

In...

08/02/2016

Journal of Clinical Pathways

ASCO‚Äôs Take on Clinical Pathways

08/02/2016

JCP Editors

Moderator Robin Zon, MD, FACP, FASCO, Michiana Hematologu Oncology PC, Chair of the ASCO Clinical Pathways Task Force, started off by providing a brief history of clinical pathways in oncology. Starting in 1985, she...

...

08/02/2016

Journal of Clinical Pathways

Research in Review

Pathways for Chronic Kidney Disease Diverse and Inconsistent

08/02/2016

JCP Editors

A scoping review published in Nephrology Dialysis Transplantation has found that clinical pathways for chronic kidney disease (CKD) are diverse in their design, content, and implementation. This information may...

...

08/02/2016

Journal of Clinical Pathways